Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association
R Pop-Busui, JL Januzzi, D Bruemmer… - Diabetes …, 2022 - Am Diabetes Assoc
Heart failure (HF) has been recognized as a common complication of diabetes, with a
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …
prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Data …
Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact
Summary The Global Diabetes Compact is a WHO-driven initiative uniting stakeholders
around goals of reducing diabetes risk and ensuring that people with diabetes have …
around goals of reducing diabetes risk and ensuring that people with diabetes have …
Prevalence and treatment of diabetes in China, 2013-2018
L Wang, W Peng, Z Zhao, M Zhang, Z Shi, Z Song… - Jama, 2021 - jamanetwork.com
Importance Recent data on prevalence, awareness, treatment, and risk factors of diabetes in
China is necessary for interventional efforts. Objective To estimate trends in prevalence …
China is necessary for interventional efforts. Objective To estimate trends in prevalence …
Trends in cardiovascular risk factors in US adults by race and ethnicity and socioeconomic status, 1999-2018
Importance After decades of decline, the US cardiovascular disease mortality rate flattened
after 2010, and racial and ethnic differences in cardiovascular disease mortality persisted …
after 2010, and racial and ethnic differences in cardiovascular disease mortality persisted …
Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations
T Ge, MR Irvin, A Patki, V Srinivasasainagendra… - Genome medicine, 2022 - Springer
Abstract Background Type 2 diabetes (T2D) is a worldwide scourge caused by both genetic
and environmental risk factors that disproportionately afflicts communities of color …
and environmental risk factors that disproportionately afflicts communities of color …
Variation in population attributable fraction of dementia associated with potentially modifiable risk factors by race and ethnicity in the US
Importance Identifying modifiable risk factors that are associated with dementia burden
across racial and ethnic groups in the population can yield insights into the potential …
across racial and ethnic groups in the population can yield insights into the potential …
Cardiovascular risk factor prevalence, treatment, and control in US adults aged 20 to 44 years, 2009 to March 2020
Importance Declines in cardiovascular mortality have stagnated in the US over the past
decade, in part related to worsening risk factor control in older adults. Little is known about …
decade, in part related to worsening risk factor control in older adults. Little is known about …
Sleep duration and risks of incident cardiovascular disease and mortality among people with type 2 diabetes
OBJECTIVE People with type 2 diabetes may have insufficient or prolonged sleep that could
accelerate cardiovascular disease (CVD) onset, but existing evidence from prospective …
accelerate cardiovascular disease (CVD) onset, but existing evidence from prospective …
National Trends in Sadness, Suicidality, and COVID-19 Pandemic–Related Risk Factors Among South Korean Adolescents From 2005 to 2021
HG Woo, S Park, H Yon, SW Lee, A Koyanagi… - JAMA network …, 2023 - jamanetwork.com
Importance Despite the COVID-19 pandemic's effect on daily life, limited research exists on
the prevalence and risk factors of suicidality and sadness among South Korean adolescents …
the prevalence and risk factors of suicidality and sadness among South Korean adolescents …
National Trends in use of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists by cardiologists and other specialties, 2015 to …
Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2is) and glucagon‐like
peptide‐1 receptor agonists (GLP‐1RAs) mitigate cardiovascular risk in individuals with type …
peptide‐1 receptor agonists (GLP‐1RAs) mitigate cardiovascular risk in individuals with type …